Submitted by Anonymous (not verified) on 13 November 2023 - 13:23
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent,dupilumab, decision type: , therapeutic area: , PIP number: P/0541/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent,dupilumab, decision type: , therapeutic area: , PIP number: P/0541/2022